145 related articles for article (PubMed ID: 28169353)
1. Human CD64-targeted non-viral siRNA delivery system for blood monocyte gene modulation.
Yong SB; Kim HJ; Kim JK; Chung JY; Kim YH
Sci Rep; 2017 Feb; 7():42171. PubMed ID: 28169353
[TBL] [Abstract][Full Text] [Related]
2. Recombinant H22(scFv) blocks CD64 and prevents the capture of anti-TNF monoclonal antibody. A potential strategy to enhance anti-TNF therapy.
Hristodorov D; Mladenov R; Brehm H; Fischer R; Barth S; Thepen T
MAbs; 2014; 6(5):1283-9. PubMed ID: 25517313
[TBL] [Abstract][Full Text] [Related]
3. An Antibody-Drug Conjugate That Selectively Targets Human Monocyte Progenitors for Anti-Cancer Therapy.
Izumi Y; Kanayama M; Shen Z; Kai M; Kawamura S; Akiyama M; Yamamoto M; Nagao T; Okada K; Kawamata N; Toyota S; Ohteki T
Front Immunol; 2021; 12():618081. PubMed ID: 33692791
[TBL] [Abstract][Full Text] [Related]
4. Granzyme B-H22(scFv), a human immunotoxin targeting CD64 in acute myeloid leukemia of monocytic subtypes.
Stahnke B; Thepen T; Stöcker M; Rosinke R; Jost E; Fischer R; Tur MK; Barth S
Mol Cancer Ther; 2008 Sep; 7(9):2924-32. PubMed ID: 18790773
[TBL] [Abstract][Full Text] [Related]
5. Phenotypical and functional characterization of Fc gamma receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity.
Grage-Griebenow E; Lorenzen D; Fetting R; Flad HD; Ernst M
Eur J Immunol; 1993 Dec; 23(12):3126-35. PubMed ID: 7504990
[TBL] [Abstract][Full Text] [Related]
6. An efficient siRNA-mediated gene silencing in primary human monocytes, dendritic cells and macrophages.
Troegeler A; Lastrucci C; Duval C; Tanne A; Cougoule C; Maridonneau-Parini I; Neyrolles O; Lugo-Villarino G
Immunol Cell Biol; 2014 Sep; 92(8):699-708. PubMed ID: 24890643
[TBL] [Abstract][Full Text] [Related]
7. Characterization of expression, cytokine regulation, and effector function of the high affinity IgG receptor Fc gamma RI (CD64) expressed on human blood dendritic cells.
Fanger NA; Voigtlaender D; Liu C; Swink S; Wardwell K; Fisher J; Graziano RF; Pfefferkorn LC; Guyre PM
J Immunol; 1997 Apr; 158(7):3090-8. PubMed ID: 9120261
[TBL] [Abstract][Full Text] [Related]
8. An Fc gamma receptor I (CD64)-negative subpopulation of human peripheral blood monocytes is resistant to killing by antigen-activated CD4-positive cytotoxic T cells.
Grage-Griebenow E; Baran J; Loppnow H; Los M; Ernst M; Flad HD; Pryjma J
Eur J Immunol; 1997 Sep; 27(9):2358-65. PubMed ID: 9341781
[TBL] [Abstract][Full Text] [Related]
9. Human monocytes expressing a CEA-specific chimeric CD64 receptor specifically target CEA-expressing tumour cells in vitro and in vivo.
Biglari A; Southgate TD; Fairbairn LJ; Gilham DE
Gene Ther; 2006 Apr; 13(7):602-10. PubMed ID: 16397508
[TBL] [Abstract][Full Text] [Related]
10. Construction and Biological Evaluation of a Novel Integrin α
Chen X; Liu M; Wang R; Yan P; Zhang C; Ma C; Yin L
Molecules; 2017 Feb; 22(2):. PubMed ID: 28165399
[TBL] [Abstract][Full Text] [Related]
11. CD64-targeted HO-1 RNA interference enhances chemosensitivity in orthotopic model of acute myeloid leukemia and patient-derived bone marrow cells.
Yong SB; Chung JY; Kim SS; Choi HS; Kim YH
Biomaterials; 2020 Feb; 230():119651. PubMed ID: 31787334
[TBL] [Abstract][Full Text] [Related]
12. PSMA specific single chain antibody-mediated targeted knockdown of Notch1 inhibits human prostate cancer cell proliferation and tumor growth.
Su Y; Yu L; Liu N; Guo Z; Wang G; Zheng J; Wei M; Wang H; Yang AG; Qin W; Wen W
Cancer Lett; 2013 Sep; 338(2):282-91. PubMed ID: 23752065
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of anti-CD64-ricin a chain immunotoxin against human acute myeloid leukemia cells in vitro and in SCID mice.
Zhong RK; van de Winkel JG; Thepen T; Schultz LD; Ball ED
J Hematother Stem Cell Res; 2001 Feb; 10(1):95-105. PubMed ID: 11276363
[TBL] [Abstract][Full Text] [Related]
14. Direct targeting of genetically modified tumour cells to Fc gammaRI triggers potent tumour cytotoxicity.
Bevaart L; Goldstein J; Vitale L; Russoniello C; Treml J; Zhang J; Graziano RF; Leusen JH; van de Winkel JG; Keler T
Br J Haematol; 2006 Feb; 132(3):317-25. PubMed ID: 16409296
[TBL] [Abstract][Full Text] [Related]
15. [Construction and expression of human anti-HER2 scFv-9R fusion protein and identification of its activity].
Jiang K; Chen R; Wang LF; Ma Q; Meng YL; Yang AG; Ma BA; Qiu XC
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Nov; 27(11):1201-3. PubMed ID: 22078448
[TBL] [Abstract][Full Text] [Related]
16. Targeted nanomedicine with anti-EGFR scFv for siRNA delivery into triple negative breast cancer cells.
Nguyen PV; Hervé-Aubert K; David S; Lautram N; Passirani C; Chourpa I; Aubrey N; Allard-Vannier E
Eur J Pharm Biopharm; 2020 Dec; 157():74-84. PubMed ID: 33059006
[TBL] [Abstract][Full Text] [Related]
17. Initial trial of bispecific antibody-mediated immunotherapy of CD15-bearing tumors: cytotoxicity of human tumor cells using a bispecific antibody comprised of anti-CD15 (MoAb PM81) and anti-CD64/Fc gamma RI (MoAb 32).
Ball ED; Guyre PM; Mills L; Fisher J; Dinces NB; Fanger MW
J Hematother; 1992; 1(1):85-94. PubMed ID: 1365020
[TBL] [Abstract][Full Text] [Related]
18. Transvascular delivery of small interfering RNA to the central nervous system.
Kumar P; Wu H; McBride JL; Jung KE; Kim MH; Davidson BL; Lee SK; Shankar P; Manjunath N
Nature; 2007 Jul; 448(7149):39-43. PubMed ID: 17572664
[TBL] [Abstract][Full Text] [Related]
19. Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells.
Fanger NA; Wardwell K; Shen L; Tedder TF; Guyre PM
J Immunol; 1996 Jul; 157(2):541-8. PubMed ID: 8752900
[TBL] [Abstract][Full Text] [Related]
20. Association of all three types of Fc gamma R (CD64, CD32, and CD16) with a gamma-chain homodimer in cultured human monocytes.
Masuda M; Roos D
J Immunol; 1993 Dec; 151(12):7188-95. PubMed ID: 8258719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
